High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil

Journal of Clinical Microbiology

Volumn 40, Issue 9, 2002, Pages 3341-3345

  Levi, José E ^a   Kleter, Bernhard ^a   Quint, Wim G V ^a   Fink, Maria C S ^a   Canto, Cynthia L M ^a   Matsubara, Regina ^a   Linhares, Iara ^a   Segurado, Aluísio ^a   Vanderborght, Bart ^a   Eluf Neto, José ^a   Van Doorn, Leen Jan ^a  

^a Delft Diagnostic Laboratory   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BRAZIL; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS; CLASSIFICATION; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX NEOPLASMS; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMAN; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; SUPPORT, NON-U.S. GOV'T; TUMOR VIRUS INFECTIONS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036708334     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.9.3341-3345.2002     Document Type: Article

References (24)

1. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients
4. Human papillomavirus testing in primary, cervical screening
5. Cervical squamous intraepithelial lesions in HIV-infected women: Prevalence, incidence and regression
6. Incidence of cervical squamous intraepithelial lesions in HIV-infected women
7. Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo, Brazil
8. Improved amplification of genital human papillomaviruses
9. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
10. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load
11. +-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
12. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia
13. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus
14. A novel shortfragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses
15. Association between HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions
16. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types: Clinical evaluation and follow-up
17. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
18. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
19. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma
20. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping
21. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
22. Epidemiologic evidence showing the HPV infection causes most cervical intraepithelial neoplasia
23. Genotyping of human papillomavirus by the PGMY-line blot assay and the SPF10 line probe assay in liquid cytology cervical specimens
24. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide